DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

Innovision Limited — Awarding of order(s)/contract(s)

NSE 1 hr ago·9 Oct 2026, 10:23 am

Innovision

Innovision Limited has announced the awarding of new orders or contracts, marking a significant development for the company. This news signals that the company has successfully secured new business, which is a positive indicator of its market position and operational momentum.

For investors, this development is generally viewed favorably as it suggests potential revenue growth and an expansion of the company's order book. It demonstrates the company's ability to compete and deliver, which can be a key driver for future earnings and valuation.

Investors should monitor the aggregate value of these new orders and the timeline for their execution. Keeping an eye on the company's future quarterly results will help determine if these new contracts translate into tangible financial performance.